Skip to content
Facebook Instagram Linkedin

LifeScienceHistory.com

History made daily

  • Home
  • DirectoryExpand
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • CareersExpand
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a RockExpand
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
LifeScienceHistory.com
History made daily
Home / Biotechnology - Page 79

Biotechnology

San Diego’s scientific and medical institutes collaborated on large-scale research program to study spread of COVID-19
Biotechnology | COVID-19 | Diagnostics | Non-Profit Research | Therapeutics

San Diego’s scientific and medical institutes collaborated on large-scale research program to study spread of COVID-19

On Jun. 16, 2020, a consortium that includes many of San Diego’s top medical and scientific research institutes…

Read More San Diego’s scientific and medical institutes collaborated on large-scale research program to study spread of COVID-19Continue

The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatment

On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) warned health care providers about a newly…

Read More The FDA warned of newly discovered potential drug interaction that may reduce effectiveness of COVID-19 treatmentContinue

The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine
Biotechnology | COVID-19 | FDA | Infectious Disease | Therapeutics

The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquine

On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) revoked the emergency use authorization (EUA) that…

Read More The FDA revoked Emergency Use Authorization for chloroquine and hydroxychloroquineContinue

The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD
Biotechnology | Diagnostics | Disease | FDA | Medical Device | Neurology | Therapeutics

The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHD

On Jun. 15, 2020, the U.S. Food and Drug Administration (FDA) permitted marketing of the first game-based digital…

Read More The FDA permitted marketing of first game-based digital therapeutic to improve attention function in children with ADHDContinue

Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine
Biotechnology | Diagnostics | Infectious Disease | Polio | Vaccine | WHO

Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccine

On Jun. 15, 2020, Batavia Biosciences and Valneva announced a collaboration agreement to accelerate market-access of a low-cost…

Read More Batavia Biosciences and Valneva collaborated to accelerate development of low-cost inactivated polio vaccineContinue

Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients
Biotechnology | COVID-19 | Infectious Disease | Therapeutics

Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patients

On Jun. 15, 2020, Humanigen announced data on the first clinical use of lenzilumab in 12 COVID-19 patients….

Read More Mayo Clinic Study of Humanigen’s lenzilumab showed rapid recovery and discharged in severe and critical COVID-19 patientsContinue

SIGA Technologies announced Department of Defense increased funding to develop posteExposure prophylactic indication for TPOXX
Biotechnology | FDA | Therapeutics

SIGA Technologies announced Department of Defense increased funding to develop posteExposure prophylactic indication for TPOXX

On Jun. 15, 2020, SIGA Technologies announced the U.S. Department of Defense (DoD) increased research and development funding…

Read More SIGA Technologies announced Department of Defense increased funding to develop posteExposure prophylactic indication for TPOXXContinue

A cluster of COVID-19 in Beijing, People’s Republic of China was reported
Biotechnology | COVID-19 | Life Science History | WHO

A cluster of COVID-19 in Beijing, People’s Republic of China was reported

On Jun. 13, 2020, officials from the WHO National Health Commission and Beijing Health Commission announced preliminary investigations…

Read More A cluster of COVID-19 in Beijing, People’s Republic of China was reportedContinue

Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir
Biotechnology | COVID-19 | Therapeutics

Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for Remdesivir

On Jun. 13, 2020, Dr. Reddy’s Laboratories announced that it had entered into a non-exclusive Licensing Agreement with…

Read More Dr. Reddy’s Laboratories entered into a licensing agreement with Gilead Sciences for RemdesivirContinue

CIRM board approved two additional COVID-19 projects
Biotechnology | COVID-19 | Non-Profit Research | Therapeutics

CIRM board approved two additional COVID-19 projects

On Jun. 12, 2020, the California Institute for Regenerative Medicine (CIRM) awarded $349,999 to Dr. Vaithilingaraja Arumugaswami at…

Read More CIRM board approved two additional COVID-19 projectsContinue

The FDA approved drug to treat infants and children with HIV
Biotechnology | CDC | HIV | Therapeutics

The FDA approved drug to treat infants and children with HIV

On Jun. 12, 2020, the U.S. Food and Drug Administration (FDA) approved ViiV Healthcare’s Tivicay (dolutegravir) tablets and…

Read More The FDA approved drug to treat infants and children with HIVContinue

InBios received FDA Emergency Use Authorization for COVID-19 antibody test
Biotechnology | COVID-19 | Diagnostics | FDA

InBios received FDA Emergency Use Authorization for COVID-19 antibody test

On Jun. 11, 2020, InBios announced that it had received Emergency Use Authorization (EUA) from the U.S. Food…

Read More InBios received FDA Emergency Use Authorization for COVID-19 antibody testContinue

NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease
Biotechnology | COVID-19 | Genomics

NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe disease

On Jun. 11, 2020, a team of researchers from the National Library of Medicine identified genomic features of…

Read More NIH researchers identified key genomic features that could differentiate SARS-CoV-2 from other coronaviruses that cause less severe diseaseContinue

FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma
Biotechnology | FDA | Medicine | Pharmaceutical | Therapeutics

FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinoma

On Jun. 11, 2020, Bristol-Myers Squibb announced that Opdivo (nivolumab) was approved by the FDA for the treatment…

Read More FDA approved Bristol-Myers’ Opdivo’ (nivolumab) for treatment of patients with advanced esophageal squamous cell carcinomaContinue

Brain cells can harbor and spread HIV virus to the body
Biotechnology | HIV | Therapeutics

Brain cells can harbor and spread HIV virus to the body

On Jun. 11, 2020, researchers have found that astrocytes, a type of brain cell can harbor HIV and…

Read More Brain cells can harbor and spread HIV virus to the bodyContinue

WHO reported cluster of COVID-19 in Beijing, China
Biotechnology | COVID-19 | WHO

WHO reported cluster of COVID-19 in Beijing, China

On Jun. 11, 2020, the World Trade Organizationメs (WTO) reported that it was following up with Chinese authorities…

Read More WHO reported cluster of COVID-19 in Beijing, ChinaContinue

Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19
Biotechnology | Diagnostics | Infectious Disease | Influenza

Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19

On Jun. 11, 2020, Quidel announced it had received funding from the Biomedical Advanced Research and Development Authority…

Read More Quidel received BARDA funding to develop point-of-care diagnostic assay that includes COVID-19Continue

Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19
Biotechnology | COVID-19 | FDA | Infectious Disease | Vaccine

Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19

On Jun. 11, 2020, Moderna announced progress on late-stage development of mRNA-1273, the Company’s mRNA vaccine candidate against…

Read More Moderna advanced late-stage development of vaccine (mRNA-1273) against COVID-19Continue

BioCryst’s galidesivir stops Zika viral replication in primate model
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics

BioCryst’s galidesivir stops Zika viral replication in primate model

On Jun. 11, 2020, BioCryst Pharmaceuticals announced new data published in Science Translational Medicine that show, in a…

Read More BioCryst’s galidesivir stops Zika viral replication in primate modelContinue

Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants
Biotechnology | COVID-19 | Therapeutics

Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutants

On Jun. 11, 2020, Regeneron announced that Science had accepted for publication two papers describing the creation of…

Read More Two science publications highlight potential of REGN-COV2 anti-viral antibody cocktail to protect against SARS-CoV-2 escape mutantsContinue

COVID-19 mouse model announced to speed search for drugs, vaccines
Biotechnology | COVID-19 | Therapeutics

COVID-19 mouse model announced to speed search for drugs, vaccines

On Jun. 10, 2020, Washington University School of Medicine in St. Louis reported they had developed a mouse…

Read More COVID-19 mouse model announced to speed search for drugs, vaccinesContinue

OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples
Biotechnology | COVID-19 | Diagnostics | Infectious Disease | Therapeutics

OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samples

On Jun. 10, 2020, OraSure Technologies announced it had been awarded a $629,217 contract from the Biomedical Advanced…

Read More OraSure received BARDA funding for Coronavirus Antibody ELISA using oral fluid samplesContinue

Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform
Biotechnology | COVID-19 | Life Science History | Vaccine

Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platform

On Jun. 10, 2020, Catalent announced that it had signed an agreement with Spicona to develop a virus-like…

Read More Catalent partnered with Spicona to develop COVID-19 vaccine candidate using GPEx cell line development platformContinue

RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in Russia
Biotechnology | COVID-19 | Therapeutics

RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in Russia

On Jun. 10, 2020, RedHill Biopharma announced it had submitted a Clinical Trial Application (CTA) with the Ministry…

Read More RedHill Biopharma submited COVID-19 clinical trial application for phase 2/3 study with Opaganib in RussiaContinue

Largest catalog of human genetic diversity released
Biotechnology | Diagnostics | Disease | Genomics | Therapeutics

Largest catalog of human genetic diversity released

On Jun. 9, 2020, an international gnomAD team of over 100 scientists released its first set of discoveries…

Read More Largest catalog of human genetic diversity releasedContinue

Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic test
Biotechnology | Diagnostics | FDA | Genomics

Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic test

On Jun. 9, 2020, Illumina announced the U.S. Food and Drug Administration (FDA) issued an Emergency Use Authorization…

Read More Illumina received first FDA Emergency Use Authorization for sequencing-based COVID-19 diagnostic testContinue

Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay
Biotechnology | COVID-19 | FDA

Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assay

On Jun. 9, 2020, Quidel announced it had received an amended Emergency Use Authorization (EUA) from the FDA,…

Read More Quidel’s received amended Emergency Authorization for rapid antigen COVID-19 diagnostic assayContinue

NIH researchers uncovered genes linked to common recurrent fever in children
Biotechnology | Diagnostics | Disease | Genomics | NIH | Therapeutics

NIH researchers uncovered genes linked to common recurrent fever in children

On Jun. 8, 2020, researchers at the National Human Genome Research Institute announced they had discovered clues to…

Read More NIH researchers uncovered genes linked to common recurrent fever in childrenContinue

Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology
Biotechnology | Infectious Disease | Influenza | Vaccine

Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technology

On Jun. 8, 2020, Intravacc and Versatope announced that they have signed a research service agreement to further…

Read More Intranasal and Versatope signed agreement to develop universal influenza vaccine based on OMV technologyContinue

Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergy
Biotechnology | Life Science History | Therapeutics

Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergy

On Jun. 8, 2020, Aimmune Therapeutics announced two-year data that suggested long-term efficacy of daily treatment with PALFORZIA…

Read More Two-year PALFORZIA data showed on-going safety and efficacy and continued immunomodulation in patients with peanut allergyContinue

Page navigation

Previous PagePrevious 1 … 77 78 79 80 81 … 161 Next PageNext
  • Categories
  • Timeline
  • Agriculture
  • Artificial Intelligence
  • Biology
  • Biotechnology
  • Cartoons – Historical
  • Cartoons – Original
  • CDC
  • CDMO
  • Chemical
  • Clinical Research
  • Cloning
  • CMO
  • COVID-19
  • CRISPR
  • CRO
  • Cryogenic
  • Dentistry
  • Diagnostics
  • Disease
  • Energy
  • Environmental
  • EPA
  • FDA
  • Forestry
  • Genomics
  • HIV
  • Infectious Disease
  • Influenza
  • IRB
  • Life Science History
  • Marine Science
  • Materials
  • Measles
  • Medical Device
  • Medicine
  • Nanotechnology
  • Neurology
  • NIH
  • Non-Profit Research
  • Nutraceuticals
  • Oncology
  • Ophthalmogy
  • Organ Transplant
  • Orthopedic
  • Other
  • Pharmaceutical
  • Plague
  • Polio
  • Prehistory
  • Radiology
  • Rare Disease
  • Stem Cell
  • Therapeutics
  • U.S. Congress
  • Uncategorized
  • USDA
  • Vaccine
  • Veterinary
  • WHO
  • Women's Health
  • 2025
  • 2024
  • 2023
  • 2022
  • 2021
  • 2020
  • 2019
  • 2018
  • 2017
  • 2016
  • 2015
  • 2014
  • 2013
  • 2012
  • 2011
  • 2010
  • 2009
  • 2008
  • 2007
  • 2006
  • 2005
  • 2004
  • 2003
  • 2002
  • 2001
  • 2000
  • 1999
  • 1998
  • 1997
  • 1996
  • 1995
  • 1994
  • 1993
  • 1992
  • 1991
  • 1990
  • 1989
  • 1988
  • 1987
  • 1986
  • 1985
  • 1984
  • 1983
  • 1982
  • 1981
  • 1980
  • 1979
  • 1978
  • 1977
  • 1976
  • 1975
  • 1974
  • 1973
  • 1972
  • 1971
  • 1970
  • 1969
  • 1968
  • 1967
  • 1966
  • 1965
  • 1964
  • 1963
  • 1962
  • 1961
  • 1960
  • 1959
  • 1958
  • 1957
  • 1956
  • 1955
  • 1954
  • 1953
  • 1952
  • 1951
  • 1950
  • 1949
  • 1948
  • 1947
  • 1946
  • 1945
  • 1944
  • 1943
  • 1942
  • 1941
  • 1940
  • 1939
  • 1938
  • 1937
  • 1936
  • 1935
  • 1934
  • 1933
  • 1932
  • 1931
  • 1930
  • 1929
  • 1928
  • 1927
  • 1926
  • 1925
  • 1924
  • 1923
  • 1922
  • 1921
  • 1920
  • 1919
  • 1918
  • 1917
  • 1916
  • 1915
  • 1914
  • 1913
  • 1912
  • 1911
  • 1910
  • 1909
  • 1908
  • 1907
  • 1906
  • 1905
  • 1904
  • 1903
  • 1902
  • 1901
  • 1900
  • 1899
  • 1898
  • 1897
  • 1896
  • 1895
  • 1894
  • 1893
  • 1892
  • 1891
  • 1890
  • 1889
  • 1888
  • 1887
  • 1886
  • 1885
  • 1884
  • 1883
  • 1882
  • 1881
  • 1880
  • 1879
  • 1878
  • 1877
  • 1876
  • 1875
  • 1874
  • 1873
  • 1872
  • 1871
  • 1870
  • 1869
  • 1868
  • 1867
  • 1866
  • 1865
  • 1864
  • 1863
  • 1862
  • 1861
  • 1860
  • 1859
  • 1858
  • 1857
  • 1856
  • 1855
  • 1854
  • 1853
  • 1852
  • 1851
  • 1850
  • 1849
  • 1848
  • 1847
  • 1846
  • 1845
  • 1844
  • 1843
  • 1842
  • 1840
  • 1839
  • 1838
  • 1837
  • 1836
  • 1834
  • 1833
  • 1832
  • 1831
  • 1830
  • 1828
  • 1827
  • 1826
  • 1825
  • 1824
  • 1823
  • 1820
  • 1819
  • 1818
  • 1817
  • 1816
  • 1813
  • 1811
  • 1810
  • 1809
  • 1808
  • 1804
  • 1802
  • 1801
  • 1800
  • 1799
  • 1798
  • 1796
  • 1795
  • 1794
  • 1793
  • 1790
  • 1789
  • 1788
  • 1786
  • 1785
  • 1784
  • 1782
  • 1781
  • 1777
  • 1769
  • 1765
  • 1761
  • 1753
  • 1751
  • 1749
  • 1747
  • 1746
  • 1743
  • 1741
  • 1738
  • 1727
  • 1723
  • 1721
  • 1720
  • 1718
  • 1716
  • 1712
  • 1697
  • 1693
  • 1683
  • 1674
  • 1667
  • 1666
  • 1665
  • 1664
  • 1663
  • 1658
  • 1656
  • 1647
  • 1636
  • 1634
  • 1629
  • 1621
  • 1603
  • 1580
  • 1521
  • 1510
  • 1403
  • 1377
  • 1370
  • 1363
  • 1348
  • 1346
  • 1322
  • 1285
  • 1202
  • 1200
  • 1179
  • 1100
  • 1050
  • 541
  • 470
  • 1
Subscribe to E-History

Subscribe

* indicates required

LifeScienceHistory.com

LifeScienceHistory.com Where history is made daily, is a comprehensive companion of life science. Simply put, we dig history and we mine data.

More

  • About
  • Life Science Heroes

Advertising

  • Life Science Banner Advertising
  • Advertise Your Life Science Jobs

Legal

  • Privacy Policy
  • Terms of Use

© 2025 LifeScienceHistory.com by James Web Design

Facebook Instagram Linkedin
  • Home
  • Directory
    • General Company Directory
    • CRO Directory
    • CMO Directory
    • Genealogy on Demand
  • Careers
    • Find Your Job
    • Advertise Your Life Science Jobs
  • News and History
  • Cartoons
  • Small World
  • Earth is a Rock
    • Earth is a Rock
    • Earth is a Rock Lyrics
    • Earth is a Rock Lyrics Defined
Search